Relay Therapeutics prices 22,916,667-share follow-on offering at $12 each

Relay Therapeutics, Inc.

Relay Therapeutics, Inc.

RLAY

0.00
  • Relay Therapeutics priced an underwritten public offering of 22,916,667 common shares at USD 12 per share.
  • Gross proceeds expected at about USD 275 million before fees, excluding any exercise of an over-allotment option.
  • Underwriters have a 30-day option to buy up to 3,437,500 additional shares.
  • Jefferies, TD Cowen, Goldman Sachs, Guggenheim Securities set as joint bookrunners.
  • Closing targeted for May 22, 2026, subject to customary conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relay Therapeutics Inc. published the original content used to generate this news brief on May 20, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.